美国与德国初级医疗中疑似阿尔茨海默病患者诊断常规的比较补充数据

该数据集提供了美国和德国初级医疗中对疑似阿尔茨海默病患者诊断常规的比较调查数据,包括诊断实践和转诊模式差异。

Taylor & FrancisTaylor & Francis
DataCite Commons
2024-05-17 更新
浏览 21
表格Alzheimer’s diseasedementiadiagnosisGermanyhealthcare researchhealth service researchUnited States
Comparison of diagnostic routines for suspected Alzheimer’s disease patients in US–American and German primary care supplement

基本信息

模态
表格
大小
0.000013567 GB
许可
CC BY 4.0
创建/更新时间
2024-05-17
版本
v1

资源简介

美国与德国初级医疗中疑似阿尔茨海默病患者诊断常规的比较补充数据

【一句话概览】

一项研究调查德国与美国医疗服务提供者对疑似阿尔茨海默病患者的诊断流程,并详细分析153名德国和88名美国专业人员的可比子样本。结果显示,德国医生自己开展AD诊断的比例低于美国同行(67% vs 99%),更常在其他机构安排诊断(65% vs 45%),但所安排诊断程序的类型无显著差异。总体而言,两国疑似AD患者的诊断流程存在差异,德国医生基于生物标志物的诊断显著更少(来源 figshare,CC BY 4.0 许可)。

【数据集背景】

本数据集源站标题为《Comparison of diagnostic routines for suspected Alzheimer’s disease patients in US–American and German primary care supplement》。配套论文《Comparison of Diagnostic Routines for Suspected Alzheimer’s Disease Patients in US–American and German Primary Care》发表于 Neurodegenerative Disease Management(2023),DOI:10.2217/nmt-2023-0023。源站首次发布:2023-12-11。

【数据内容】

源站原始描述:Aim: Thorough diagnostics are a prerequisite for the optimal treatment of Alzheimer’s disease (AD). Biomarker-based diagnostics are standard in academia, data on practitioners’ diagnostic workups is scarce. Materials & methods: Surveys in German and US healthcare providers (HCP) were conducted regarding diagnostics in presumed AD patients. A subsample of 153 German and 88 US professionals was analyzed in detail. Results: Fewer German physicians conduct AD diagnostics themselves compared with US…

【数据结构与技术规格】

文件数 1 个,合计 13.57 KB。20220627_Supplement.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,13.57 KB。数据集 DOI:10.25402/NMT.24763386.v1。

【主题与分类】

主题标签:Alzheimer’s disease、dementia、diagnosis、Germany、healthcare research、health service research、United States。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/Comparison_of_diagnostic_routines_for_suspected_Alzheimer_s_disease_patients_in_US_American_and_German_primary_care_supplement/24763386

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Comparison of diagnostic routines for suspected Alzheimer’s disease patients in US–American and German primary care supplement. Taylor & Francis. Menne, Felix; Grimmer, Timo; G Schipke, Carola

【使用注意】

· 源站最后修改于 2024-05-17,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

免费样本无法满足模型训练要求?千方提供经三甲医院脱敏、带病理回证与专家标注的商业级专病数据集。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "20220627_Supplement.docx" "https://ndownloader.figshare.com/files/43510737"

文件清单

  • 20220627_Supplement.docx(13.57 KB)

文件总体积 13.57 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Aim: Thorough diagnostics are a prerequisite for the optimal treatment of Alzheimer’s disease (AD). Biomarker-based diagnostics are standard in academia, data on practitioners’ diagnostic workups is scarce. Materials & methods: Surveys in German and US healthcare providers (HCP) were conducted regarding diagnostics in presumed AD patients. A subsample of 153 German and 88 US professionals was analyzed in detail. Results: Fewer German physicians conduct AD diagnostics themselves compared with US colleagues (67% vs 99%; p Conclusion: Diagnostic routines for suspected AD patients differ between German and US–American healthcare providers.
Plain language summary: It is important to conduct the best-possible tests to come to a correct diagnosis of Alzheimer’s disease (AD). This ensures choosing the optimal treatment. In academic surroundings such as specialized memory clinics, so called biomarkers (found for example in blood) are an important component in finding the correct diagnosis. However, there is limited data on the methods healthcare providers (HCP) use in their everyday clinical practice. With this study, we aimed to get a clearer picture of the differences in the diagnostic routines for potential AD patients implemented by HCPs in two highincome countries, Germany and the USA. We conducted two surveys in 500 German and 100 US HCPs on their AD-diagnostic routines. A comparable subsample of 153 German and 88 US professionals was analyzed in detail.We found that fewer German physicians conduct AD diagnostics themselves compared with their US–American colleagues (67% vs 99%). The other way around, German doctors more often order diagnostics at other institutions (65% vs 45%). However, there were no significant differences in the type of diagnostic procedures ordered at other institutions. In conclusion, diagnostic routines for suspected AD patients differ between German and US–American healthcare providers, such as biomarkerbased diagnostics, which German physicians significantly perform less often.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.25402/NMT.24763386.v1(source: https://tandf.figshare.com/articles/dataset/Comparison_of_diagnostic_routines_for_suspected_Alzheimer_s_disease_patients_in_US_American_and_German_primary_care_supplement/24763386)。

需要用于商业化训练或医疗器械注册(NMPA/FDA)?

公开数据往往缺乏完整的病理回证与专家标注。千方医数集依托陕川双基地与超十家三甲医院直连,提供完全合规、去标识化、支持注册级质控的专病数据集交易服务。